Gao, J. ., Ward, J. ., Pettaway, C. ., Shi, L. ., Subudhi, S. ., Vence, L. ., … Sharma, P. . (2017). VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. Nature Medicine, 23(5), 551-555. https://doi.org/10.1038/nm.4308